Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 8224-8230

  Ishida, Waka ^a   Fukuda, Ken ^a   Sakamoto, Shuji ^a   Koyama, Noriko ^b   Koyanagi, Akemi ^b   Yagita, Hideo ^b   Fukushima, Atsuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE LIGAND 4 ANTIBODY; GAMMA INTERFERON; GAMMA SECRETASE INHIBITOR; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; NOTCH RECEPTOR; PERTUSSIS TOXIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CYTOKINE; DLL4 PROTEIN, MOUSE; EYE PROTEIN; INTERSTITIAL RETINOL-BINDING PROTEIN; MEMBRANE PROTEIN; NOTCH1 PROTEIN, MOUSE; NOTCH1 RECEPTOR; NOTCH2 PROTEIN, MOUSE; NOTCH2 RECEPTOR; NOTCH4 PROTEIN, MOUSE; ONCOPROTEIN; PEPTIDE FRAGMENT; RETINOL BINDING PROTEIN; SECRETASE; SIGNAL PEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; FLOW CYTOMETRY; HISTOLOGY; HISTOPATHOLOGY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SPLEEN CELL; UVEORETINITIS; ANIMAL; AUTOIMMUNE DISEASE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; RETINITIS; UVEITIS;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; EYE PROTEINS; FLOW CYTOMETRY; INJECTIONS, INTRAPERITONEAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; RECEPTORS, NOTCH; RETINITIS; RETINOL-BINDING PROTEINS; RNA, MESSENGER; UVEITIS;

EID: 84855384313     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7756     Document Type: Article

References (38)

1. George RK, Chan CC, Whitcup SM, Nussenblatt RB. Ocular immunopathology of Behçet's disease. Surv Ophthalmol. 1997;42:157-162.
2. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14:303-308.
3. Boyd SR, Young S, Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol. 2001;46:209-233.
4. Nussenblatt RB, Salinas-Carmona M, Waksman BH, Gery I. Cyclosporin A: alterations of the cellular immune response in S-antigeninduced experimental autoimmune uveitis. Int Arch Allergy Appl Immunol. 1983;70:289-294.
5. Caspi RR, Roberge FG, Chan CC, et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol. 1988;140: 1490-1495.
6. Mochizuki M, Kuwabara T, McAllister C, Nussenblatt RB, Gery I. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci. 1985;26:1-9.
7. Caspi RR. Immunogenetic aspects of clinical and experimental uveitis. Reg Immunol. 1992;4:321-330.
8. Caspi RR, Silver PB, Chan CC, et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol. 1996;157:2668-2675.
9. Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/ STAT1. Nat Med. 2007;13:711-718.
10. Yoshimura T, Sonoda KH, Miyazaki Y, et al. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol. 2008;20:209-214.
11. Shao H, Fu Y, Liao T, et al. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T-cells. Invest Ophthalmol Vis Sci. 2005;46:596-603.
12. Usui Y, Akiba H, Takeuchi M, et al. The role of the ICOS/B7RP-1 T-cell costimulatory pathway in murine experimental autoimmune uveoretinitis. Eur J Immunol. 2006;36:3071-3081.
13. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284: 770-776.
14. Lindsell CE, Boulter J, diSibio G, Gossler A, Weinmaster G. Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development. Mol Cell Neurosci. 1996;8:14-27.
15. Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 2004;117:515-526.
16. Kostianovsky AM, Maier LM, Baecher-Allan C, Anderson AC, Anderson DE. Up-regulation of gene related to anergy in lymphocytes is associated with Notch-mediated human T-cell suppression. J Immunol. 2007;178:6158-6163.
17. + T-cells. Immunity. 2003;19:549-559.
18. Rutz S, Mordmuller B, Sakano S, Scheffold A. Notch ligands Deltalike1, Delta-like4 and Jagged1 differentially regulate activation of peripheral T helper cells. Eur J Immunol. 2005;35:2443-2451.
19. Skokos D, Nussenzweig MC. CD8-DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med. 2007;204:1525-1531.
20. Fukushima A, Sumi T, Ishida W, et al. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis. Immunol Lett. 2008;121:140-147.
21. Moriyama Y, Sekine C, Koyanagi A, et al. Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice. Int Immunol. 2008;20:763-773.
22. Caspi RR. Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol. 2003; Chapter 15:Unit 15.6.
23. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12:21-27.
24. + uveitogenic T-cells. J Immunol. 2009;183: 560-567.
25. + uveitogenic T-cells. Invest Ophthalmol Vis Sci. 2010;51:4661-4667.
26. Kitaichi N, Kotake S, Morohashi T, Onoé K, Ohno S, Taylor AW. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J Leukoc Biol. 2002;72:1117-1121.
27. Grajewski RS, Hansen AM, Agarwal RK, et al. Activation of invariant NKT-cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J Immunol. 2008; 181:4791-4797.
28. Oh K, Byoun OJ, Ham DI, Kim YS, Lee DS. Invariant NKT-cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation. Eur J Immunol. 2011;41:392-402.
29. Jang S, Schaller M, Berlin AA, Lukacs NW. Notch ligand delta-like 4 regulates development and pathogenesis of allergic airway responses by modulating IL-2 production and Th2 immunity. J Immunol. 2010;185:5835-5844.
30. Ishida W, Fukuda K, Higuchi T, Kajisako M, Sakamoto S, Fukushima A. Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 2011;52:611-617.
31. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008;205:799-810.
32. Mukherjee S, Schaller MA, Neupane R, Kunkel SL, Lukacs NW. Regulation of T-cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J Immunol. 2009;182:7381-7388.
33. Takeichi N, Yanagisawa S, Kaneyama T, et al. Ameliorating effects of anti-Dll4 mAb on Theiler's murine encephalomyelitis virusinduced demyelinating disease. Int Immunol. 2010;22:729-738.
34. Palaga T, Buranaruk C, Rengpipat S, et al. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur J Immunol. 2008;38:174-183.
35. Bugeon L, Gardner LM, Rose A, Gentle M, Dallman MJ. Notch signaling induces a distinct cytokine profile in dendritic cells that supports T-cell-mediated regulation and IL-2-dependent IL-17 production. J Immunol. 2008;181:8189-8193.
36. Imaeda H, Andoh A, Aomatsu T, et al. Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. Int J Mol Med. 2011; 28: 573-578.
37. Minter LM, Turley DM, Das P, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol. 2005;6:680-688.
38. Jurynczyk M, Jurewicz A, Raine CS, Selmaj K. Notch3 inhibition in myelin-reactive T-cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. J Immunol. 2008;180:2634-2640.